Long term follow-up of infliximab efficacy in pulmonary and extra-pulmonary sarcoidosis refractory to conventional therapy

Overview of attention for article published in Seminars in Arthritis & Rheumatism, January 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

policy: 1 policy source

Readers on

mendeley: 71 Mendeley

So far, Altmetric has seen 2 policy documents that reference this research output.

Refractory extrapulmonary sarcoidosis: infliximab

Cited by National Institute for Health and Care Excellence (NICE) on 01 Jan 2017

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Pulmonary sarcoidosis: infliximab

Cited by National Institute for Health and Care Excellence (NICE) on 01 Dec 2016

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.